Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Immunohistochemical features of proliferative marker and basement membrane components of two feline inductive odontogenic tumours.

Sakai H, Mori T, Iida T, Tokuma Y, Maruo K, Masegi T.

J Feline Med Surg. 2008 Jul;10(3):296-9. Epub 2007 Sep 4.

PMID:
17766158
2.

[Development of software for data analysis by therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic].

Niwa T, Tokuma Y, Ito T, Kimura J, Tabata K, Takagi A.

Jpn J Antibiot. 2004 Aug;57(4):413-9. Japanese.

PMID:
15535042
3.

Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.

Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.

Drug Metab Dispos. 2000 Sep;28(9):1128-34.

PMID:
10950860
4.

Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans.

Katashima M, Yamamoto K, Tokuma Y, Hata T, Sawada Y, Iga T.

Eur J Drug Metab Pharmacokinet. 1998 Jan-Mar;23(1):19-26.

PMID:
9625268
5.

Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5 alpha-reductase, in healthy volunteers.

Katashima M, Irino T, Shimojo F, Kawamura A, Kageyama H, Higashi N, Miyao Y, Tokuma Y, Hata T, Yamamoto K, Sawada Y, Iga T.

Clin Pharmacol Ther. 1998 Mar;63(3):354-66.

PMID:
9542479
6.
7.
8.

A species comparison of 14C-labeled 7-ethoxycoumarin metabolism in precision-cut liver slices from guinea pig and dog using a phosphor imaging system.

Terada T, Kaneko H, Terashita S, Tozuka Z, Tokuma Y, Hata T.

Res Commun Mol Pathol Pharmacol. 1996 Jan;91(1):41-56.

PMID:
8824930
9.

Stereoselective pharmacokinetics of dihydropyridine calcium antagonists.

Tokuma Y, Noguchi H.

J Chromatogr A. 1995 Mar 3;694(1):181-93. Review.

PMID:
7719464
10.

Sex-dependent and independent renal excretion of nilvadipine metabolites in rat: evidence for a sex-dependent active secretion in kidney.

Terashita S, Sawamoto T, Deguchi S, Tokuma Y, Hata T.

Xenobiotica. 1995 Jan;25(1):37-47.

PMID:
7604605
11.

Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.

Iwasaki K, Shiraga T, Matsuda H, Nagase K, Tokuma Y, Hata T, Fujii Y, Sakuma S, Fujitsu T, Fujikawa A, et al.

Drug Metab Dispos. 1995 Jan;23(1):28-34.

PMID:
7536652
12.
13.

Age- and sex-related changes of sulfotransferase activities in the rat.

Iwasaki K, Tokuma Y, Noda K, Noguchi H.

Chem Biol Interact. 1994 Jun;92(1-3):209-17.

PMID:
8033254
14.

Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes.

Iwasaki K, Matsuda H, Nagase K, Shiraga T, Tokuma Y, Uchida K.

Res Commun Chem Pathol Pharmacol. 1993 Nov;82(2):209-16.

PMID:
7508138
15.

Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride.

Takakura S, Sogabe K, Satoh H, Mori J, Fujiwara T, Totsuka Z, Tokuma Y, Kohsaka M.

Neurosci Lett. 1992 Jul 20;141(2):199-202. Erratum in: Neurosci Lett 1993 Jul 9;157(1):121.

PMID:
1436634
16.

Sex differences in the metabolism and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats.

Terashita S, Tokuma Y, Sekiguchi M, Noguchi H.

Xenobiotica. 1989 Nov;19(11):1221-9.

PMID:
2618076
17.

Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog.

Tokuma Y, Fujiwara T, Niwa T, Hashimoto T, Noguchi H.

Res Commun Chem Pathol Pharmacol. 1989 Feb;63(2):249-62.

PMID:
2711027
18.

Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver.

Niwa T, Tokuma Y, Nakagawa K, Noguchi H.

Drug Metab Dispos. 1989 Jan-Feb;17(1):64-8.

PMID:
2566472
19.

Stereoselective oxidation and plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man.

Niwa T, Tokuma Y, Nakagawa K, Noguchi H, Yamazoe Y, Kato R.

Res Commun Chem Pathol Pharmacol. 1988 May;60(2):161-72.

PMID:
3393731
20.

Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers.

Terakawa M, Tokuma Y, Kuwahara N, Shishido A, Noguchi H.

J Clin Pharmacol. 1988 Apr;28(4):350-5.

PMID:
3392233
21.
22.

Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs.

Tokuma Y, Sekiguchi M, Niwa T, Noguchi H.

Xenobiotica. 1988 Jan;18(1):21-8.

PMID:
3354229
23.

Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.

Terashita S, Tokuma Y, Fujiwara T, Shiokawa Y, Okumura K, Noguchi H.

Xenobiotica. 1987 Dec;17(12):1415-25.

PMID:
3439192
24.
25.

Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.

Tokuma Y, Fujiwara T, Noguchi H.

Res Commun Chem Pathol Pharmacol. 1987 Aug;57(2):229-37.

PMID:
3659571
26.

Effect of two different meals on bioavailability of nilvadipine in healthy volunteers.

Terakawa M, Tokuma Y, Shishido A, Yasuda K, Noguchi H.

J Clin Pharmacol. 1987 Apr;27(4):293-6.

PMID:
3680587
28.

Determination of nilvadipine in plasma and urine by capillary column gas chromatography with electron-capture detection.

Tokuma Y, Fujiwara T, Sekiguchi M, Noguchi H.

J Chromatogr. 1987 Mar 20;415(1):156-62. No abstract available.

PMID:
3584351
29.

Pharmacokinetics of nilvadipine in healthy volunteers.

Terakawa M, Tokuma Y, Shishido A, Noguchi H.

J Clin Pharmacol. 1987 Feb;27(2):111-7.

PMID:
3680562
30.

Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.

Niwa T, Tokuma Y, Noguchi H.

Res Commun Chem Pathol Pharmacol. 1987 Jan;55(1):75-88.

PMID:
3563108
31.
32.
34.

Pharmacokinetics of prifinium bromide in healthy volunteers.

Noguchi H, Tokuma Y, Tamura Y.

Int J Clin Pharmacol Ther Toxicol. 1983 May;21(5):213-7.

PMID:
6134685
35.
36.

A quantitative assay of phagocytosis using liposomes with trapped spin labels.

Tsuge I, Kiyotaki C, Yamamura Y, Ito M, Tokuma Y, Shimizu A.

J Reticuloendothel Soc. 1982 May;31(5):405-13. No abstract available.

PMID:
6288937
37.

Structure of enterocin; X-ray analysis of m-Bromobenzoyl enterocin dihydrate.

Tokuma Y, Miyairi N, Morimoto Y.

J Antibiot (Tokyo). 1976 Oct;29(10):1114-6. No abstract available.

38.

Isolation of carcinogenic aminoazo dye-binding protein and its identification as alcohol dehydrogenase.

Tokuma Y, Terayama H.

Biochem Biophys Res Commun. 1973 Sep 5;54(1):341-9. No abstract available.

PMID:
4200396

Supplemental Content

Loading ...
Support Center